Susceptibility to reinfection with SARS-CoV-2 virus relative to existing antibody concentrations and T cell response
- PMID: 36702370
- PMCID: PMC9870609
- DOI: 10.1016/j.ijid.2023.01.006
Susceptibility to reinfection with SARS-CoV-2 virus relative to existing antibody concentrations and T cell response
Abstract
Objectives: We investigated the reinfection rate of vaccinated or convalescent immunized SARS-CoV-2 in 952 expatriate workers with SARS-CoV-2 serological antibody (Ab) patterns and surrogate T cell memory at recruitment and follow-up.
Methods: Trimeric spike, nucleocapsid, and neutralizing Abs were measured, along with a T cell stimulation assay, targeting SARS-CoV-2 memory in clusters of differentiation (CD) 4+ and CD8+ T cells. The subjects were then followed up for reinfection for up to 6 months.
Results: The seroprevalence positivity at enrollment was greater than 99%. The T cell reactivity in this population was 38.2%. Of the 149 (15.9%) participants that were reinfected during the follow-up period (74.3%) had nonreactive T cells at enrollment. Those who had greater than 100 binding Ab units/ml increase from the median concentration of antispike immunoglobulin G Abs had a 6% reduction in the risk of infection. Those who were below the median concentration had a 78% greater risk of infection.
Conclusion: Significant immune protection from reinfection was observed in those who retained T cell activation memory. Additional protection was observed when the antispike was greater than the median value.
Keywords: Neutralizing antibodies; Reinfection; SARS-CoV-2 immunocompetence; Seroprevalence; Spike and receptor binding protein antibodies; T cell response.
Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors have no competing interests to declare.
Figures
References
-
- Centers for Disease Control and Prevention. Covid-19- large-scale geographic seroprevalence surveys, https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/geographic-serop...; 2020 [accessed 31 May 2022].
-
- World Health Organization. Population-based age-stratified seroepidemiological investigation protocol for coronavirus 2019 (COVID-19) infection, 26 May 2020, version 2.0, https://apps.who.int/iris/handle/10665/332188; 2020 [accessed 31 January 2021].
-
- Alsuwaidi AR, Al Hosani FI, Al Memari S, Narchi H, Abdel Wareth L, Kamal H, Al Ketbi M, Al Baloushi D, Elfateh A, Khudair A, Al Mazrouei S, Al Humaidan HS, Alghaithi N, Afsh K, Al Kaabi N, Altrabulsi B, Jones M, Shaban S, Sheek-Hussein M, Zoubeidi T. Seroprevalence of COVID-19 infection in the Emirate of Abu Dhabi, United Arab Emirates: a population-based cross-sectional study. Int J Epidemiol. 2021;50:1077–1090. doi: 10.1093/ije/dyab077. - DOI - PMC - PubMed
-
- Official Portal of the Government. Labour housing regulations, Government of the United Arab Emirates, https://u.ae/en/information-and-services/jobs/labour-accomodation; 2022 (accessed 16 August 2022).
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
